Concepedia

A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane

J. A. Ajani, Howard Safran, Carsten Bokemeyer, Manish A. Shah, Heinz‐Josef Lenz, Eric Van Cutsem, Howard A. Burris, David Lebwohl, Brian P. Mullaney

Investigational New Drugs · 2006 · 34 citations · 12 references

DOI

Concepts

References

12

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action

Suzanne B. Buck, Sam F. Victory, Richard H. Himes et al. · 1998 · 983 citations

, , +10

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.

Daniel M. Bollag, Patricia A. McQueney, Jian‐Yong Zhu et al. · PubMed · 1995 · 686 citations

, , +15

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Francis Y. F. Lee, R. M. Borzilleri, Craig R. Fairchild et al. · PubMed · 2001 · 455 citations

, , +13